To access this element change to forms mode OFF
Grant Award View - GA29777
The designer cytokine IC7: a novel therapy for the treatment of type 2...
GA ID:
GA29777
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$1,081,560.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
The designer cytokine IC7: a novel therapy for the treatment of type 2 Diabetes
Purpose:
Obesity is a world pandemic in the new millennium. It leads to many diseases including type 2 diabetes (T2D). T2D is degenerative, leading to profound health effects. Current therapies are inadequate and approximately half of those diagnosed and being treated are unable to control their disease. Ongoing work in our laboratories has led to the development of a novel protein IC7 which we will test as novel therapeutic strategy for the treatment of T2D.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1156511
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Garvan Institute of Medical Research
Recipient ABN:
62 330 391 937
Grant Recipient Location
Suburb:
Darlinghurst
Town/City:
Darlinghurst
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, GERMANY